These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34911656)

  • 1. Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma.
    Austin EJ; Tsui JI; Barry MP; Tung E; Glick SN; Ninburg M; Williams EC
    J Subst Abuse Treat; 2022 Jun; 137():108684. PubMed ID: 34911656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
    Muncan B; Walters SM; Ezell J; Ompad DC
    Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
    Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
    Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies used by people who inject drugs to avoid stigma in healthcare settings.
    Biancarelli DL; Biello KB; Childs E; Drainoni M; Salhaney P; Edeza A; Mimiaga MJ; Saitz R; Bazzi AR
    Drug Alcohol Depend; 2019 May; 198():80-86. PubMed ID: 30884432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.
    Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
    Int J Drug Policy; 2021 Oct; 96():103238. PubMed ID: 33902968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration.
    Ward KM; McCormick SD; Sulkowski M; Latkin C; Chander G; Falade-Nwulia O
    Int J Drug Policy; 2021 Feb; 88():103019. PubMed ID: 33160152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
    Goodyear T; Ti L; Carrieri P; Small W; Knight R
    Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stigma at every turn: Health services experiences among people who inject drugs.
    Paquette CE; Syvertsen JL; Pollini RA
    Int J Drug Policy; 2018 Jul; 57():104-110. PubMed ID: 29715589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
    Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
    Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study.
    Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C
    Int J Drug Policy; 2024 Jul; 129():104477. PubMed ID: 38861842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs.
    Austin EJ; Gojic AJ; Bhatraju EP; Pierce KA; Pickering EI; Tung EL; Scott JD; Hansen RN; Glick SN; Stekler JD; Connolly NC; Villafuerte S; McPadden M; Deutsch S; Ninburg M; Kubiniec R; Williams EC; Tsui JI
    Int J Drug Policy; 2023 Jan; 111():103924. PubMed ID: 36521197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia.
    Djordjevic F; Ryan K; Gunn J; Brener L; O'Keefe D; Draper B; Schroeder S; Gold J; Treloar C; Broady T; Dietze P; Hellard M; Pedrana A
    J Viral Hepat; 2021 Dec; 28(12):1738-1743. PubMed ID: 34510655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs.
    Karasz A; Singh R; McKee MD; Merchant K; Kim AY; Page K; Pericot-Valverde I; Stein ES; Taylor LE; Wagner K; Litwin AH
    J Subst Abuse Treat; 2022 Sep; 140():108768. PubMed ID: 35729038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.
    Patel EU; Solomon SS; Lucas GM; McFall AM; Tomori C; Srikrishnan AK; Kumar MS; Laeyendecker O; Celentano DD; Thomas DL; Quinn TC; Mehta SH
    Int J Drug Policy; 2021 Oct; 96():103354. PubMed ID: 34247900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
    Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
    BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
    Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
    Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.
    Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Bahramnejad A; Barshan A; Mousavian G; Najafi E; Sharifi H; Haghdoost AA; Briceno A; McFarland W; Page K
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):56. PubMed ID: 32758246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs.
    Skeer MR; Ladin K; Wilkins LE; Landy DM; Stopka TJ
    Drug Alcohol Depend; 2018 Sep; 190():246-254. PubMed ID: 30071457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs.
    Williams LD; Mackesy-Amiti ME; Latkin C; Boodram B
    Drug Alcohol Depend; 2021 Apr; 221():108626. PubMed ID: 33689967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.